Revenue from Contracts with Customers (Tables)

3 Months Ended

Mar. 31, 2023

Disaggregation of Revenue [Line Items]

Sales Reserves Rollforward

The following table reflects activity in the Company's sales reserve accounts:

	Rebates and Chargebacks (1)		Product Returns		Other Sales Deductions		Total
Balance as of December 31, 2021 (Predecessor)	$	241.8	$	21.5	$	9.5	$	272.8
Provisions	370.8		2.4		9.7		382.9
Payments or credits	(412.0)		(4.3)		(10.0)		(426.3)
Balance as of April 1, 2022 (Predecessor)	$	200.6	$	19.6	$	9.2	$	229.4
Balance as of December 30, 2022 (Successor)	$	265.3	$	16.0	$	12.7	$	294.0
Provisions	355.6		3.2		9.5		368.3
Payments or credits	(404.3)		(4.0)		(15.0)		(423.3)
Balance as of March 31, 2023 (Successor)	$	216.6	$	15.2	$	7.2	$	239.0

Disaggregation of Revenue

Product sales transferred to customers at a point in time and over time were as follows:

	Successor		Predecessor
	Three Months Ended March 31, 2023		Three Months Ended April 1, 2022
Product sales transferred at a point in time	80.2	%	79.5	%
Product sales transferred over time	19.8		20.5

The associated royalty revenue recognized was as follows:

	Successor		Predecessor
	Three Months Ended March 31, 2023		Three Months Ended April 1, 2022
Royalty revenue	$	3.4	$	20.0

Contract with Customer, Timing of Satisfaction of Performance Obligation and Payment

The following table includes estimated revenue from contracts extending greater than one year for certain of the Company's hospital products that are expected to be recognized in the future related to performance obligations that were unsatisfied or partially unsatisfied as of March 31, 2023 (Successor):

Remainder of Fiscal 2023	$	56.6
Fiscal 2024	37.7
Fiscal 2025	13.2
Thereafter	0.2